British Journal of Cancer - Table of Contents alert Volume 107 Issue 11

TABLE OF CONTENTS Volume 107, Issue 11 (1797-1916) Published online 20 November 2012 In this issue Clinical Studies Translational Therapeutics Molecular Diagnostics Epidemiology Letter to the Editor Also new today Advance online publication Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement British Journal of Cancer presents: Guidelines for the Welfare of Animals in Cancer Research, 2010 Updated, enhanced, and providing practical advice on animal welfare specifically for today's cancer researchers, these guidelines define and encourage sharing of best practice in laboratory work. Already endorsed by leading scientists worldwide, they should also be read by those making decisions about licensing, funding and publication. Read the guidelines here.   Clinical Studies Top Association of creatine kinase and skin toxicity in phase I trials of anticancer agents V Moreno Garcia, P Thavasu, M Blanco Codesido, L R Molife, J Vitfell Pedersen, M Puglisi, B Basu, K Shah, J Iqbal, J S de Bono, S B Kaye and U Banerji Br J Cancer 2012 107: 1797-1800; advance online publication, October 25, 2012; 10.1038/bjc.2012.482 Abstract | Full Text Smaller sample sizes for phase II trials based on exact tests with actual error rates by trading-off their nominal levels of significance and power I Khan, S-J Sarker and A Hackshaw Br J Cancer 2012 107: 1801-1809; 10.1038/bjc.2012.444 Abstract | Full Text Treatment outcomes for 618 women with gestational trophoblastic tumours following a molar pregnancy at the Charing Cross Hospital, 2000–2009 A Sita-Lumsden, D Short, I Lindsay, N J Sebire, D Adjogatse, M J Seckl and P M Savage Br J Cancer 2012 107: 1810-1814; advance online publication, October 11, 2012; 10.1038/bjc.2012.462 Abstract | Full Text Efficacy of adjuvant aromatase inhibitor in hormone receptor-positive postmenopausal breast cancer patients according to the body mass index M A N Sendur, S Aksoy, N Zengin and K Altundag Br J Cancer 2012 107: 1815-1819; advance online publication, October 25, 2012; 10.1038/bjc.2012.473 Abstract | Full Text VeriStrat® has prognostic value in advanced stage NSCLC patients treated with erlotinib and sorafenib J L Kuiper, J S W Lind, H J M Groen, J Roder, J Grigorieva, H Roder, A M C Dingemans and E F Smit Br J Cancer 2012 107: 1820-1825; advance online publication, October 18, 2012; 10.1038/bjc.2012.470 Abstract | Full Text Risk stratification of pT1-3N0 patients after radical cystectomy for adjuvant chemotherapy counselling E Xylinas, E K Cha, M Sun, M Rink, Q-D Trinh, G Novara, D A Green, A Pycha, Y Fradet, S Daneshmand, R S Svatek, H-M Fritsche, W Kassouf, D S Scherr, T Faison, J J Crivelli, S T Tagawa, M Zerbib, P I Karakiewicz and S F Shariat Br J Cancer 2012 107: 1826-1832; 10.1038/bjc.2012.464 Abstract | Full Text Sperm counts and endocrinological markers of spermatogenesis in long-term survivors of testicular cancer M Brydøy, S D Fosså, O Klepp, R M Bremnes, E A Wist, T Bjøro, T Wentzel-Larsen and O Dahl for the Norwegian Urology Cancer Group (NUCG) III study group Br J Cancer 2012 107: 1833-1839; 10.1038/bjc.2012.471 Abstract | Full Text Translational Therapeutics Top Association of transcobalamin c. 776C>G with overall survival in patients with primary central nervous system lymphoma M Linnebank, S Moskau, A Kowoll, A Semmler, C Bangard, M Vogt-Schaden, G Egerer, G Schackert, H Reichmann, I G H Schmidt-Wolf, H Pels and U Schlegel Br J Cancer 2012 107: 1840-1843; advance online publication, October 25, 2012; 10.1038/bjc.2012.476 G with overall survival in patients with primary central nervous system lymphoma" href="http://www.nature.com/bjc/journal/v107/n11/abs/bjc2012476a.html?WT.ec_id=BJC-201211">Abstract | G with overall survival in patients with primary central nervous system lymphoma" href="http://www.nature.com/bjc/journal/v107/n11/full/bjc2012476a.html?WT.ec_id=BJC-201211">Full Text Differential downregulation of telomerase activity by bortezomib in multiple myeloma cells-multiple regulatory pathways in vitro and ex vivo C Weiss, O Uziel, O Wolach, J Nordenberg, E Beery, S Bulvick, G Kanfer, O Cohen, R Ram, M Bakhanashvili, H Magen-Nativ, N Shilo and M Lahav Br J Cancer 2012 107: 1844-1852; 10.1038/bjc.2012.460 Abstract | Full Text Anti-tumour activity of two novel compounds in cisplatin-resistant testicular germ cell cancer B Nitzsche, C Gloesenkamp, M Schrader, B Hoffmann, F Zengerling, S Balabanov, F Honecker and M Höpfner Br J Cancer 2012 107: 1853-1863; 10.1038/bjc.2012.481 Abstract | Full Text Molecular Diagnostics Top EGFR and K-ras gene mutation status in squamous cell anal carcinoma: a role for concurrent radiation and EGFR inhibitors? A Paliga, R Onerheim, A Gologan, G Chong, A Spatz, T Niazi, A Garant, D Macheto, T Alcindor and T Vuong Br J Cancer 2012 107: 1864-1868; advance online publication, October 23, 2012; 10.1038/bjc.2012.479 Abstract | Full Text VEGF directly suppresses activation of T cells from ascites secondary to ovarian cancer via VEGF receptor type 2 N G Gavalas, M Tsiatas, O Tsitsilonis, E Politi, K Ioannou, A C Ziogas, A Rodolakis, G Vlahos, N Thomakos, D Haidopoulos, E Terpos, A Antsaklis, M A Dimopoulos and A Bamias Br J Cancer 2012 107: 1869-1875; 10.1038/bjc.2012.468 Abstract | Full Text Calprotectin: a novel biomarker for the diagnosis of pleural effusion N Sánchez-Otero, S Blanco-Prieto, M Páez de la Cadena, L Vázquez-Iglesias, A Fernández-Villar, M I Botana-Rial and F J Rodríguez-Berrocal Br J Cancer 2012 107: 1876-1882; advance online publication, October 23, 2012; 10.1038/bjc.2012.478 Abstract | Full Text Serum apolipoprotein C-II is prognostic for survival after pancreatic resection for adenocarcinoma A Xue, J W Chang, L Chung, J Samra, T Hugh, A Gill, G Butturini, R C Baxter and R C Smith Br J Cancer 2012 107: 1883-1891; 10.1038/bjc.2012.458 Abstract | Full Text Thymosin beta 15A (TMSB15A) is a predictor of chemotherapy response in triple-negative breast cancer S Darb-Esfahani, R Kronenwett, G von Minckwitz, C Denkert, M Gehrmann, A Rody, J Budczies, J C Brase, M K Mehta, H Bojar, B Ataseven, T Karn, E Weiss, D M Zahm, F Khandan, M Dietel and S Loibl Br J Cancer 2012 107: 1892-1900; advance online publication, October 18, 2012; 10.1038/bjc.2012.475 Abstract | Full Text Epidemiology Top Influence of comorbidity on the effect of adjuvant treatment and age in patients with early-stage breast cancer L H Land, S O Dalton, M-B Jensen and M Ewertz Br J Cancer 2012 107: 1901-1907; advance online publication, October 18, 2012; 10.1038/bjc.2012.472 Abstract | Full Text Ethnicity in relation to incidence of oesophageal and gastric cancer in England V H Coupland, J Lagergren, J Konfortion, W Allum, M A Mendall, R H Hardwick, K M Linklater, H Møller and R H Jack Br J Cancer 2012 107: 1908-1914; advance online publication, October 11, 2012; 10.1038/bjc.2012.465 Abstract | Full Text Letter to the Editor Top Hypertensive diseases in pregnancy and subsequent lower risk of breast cancer: the common immune and antiangiogenic profile L Carbillon Br J Cancer 2012 107: 1915-1916; advance online publication, October 23, 2012; 10.1038/bjc.2012.487 Full Text Advertisement Ensure your access to British Journal of Cancer If you are unable to access the articles in this Table of Contents e-alert, your library may not subscribe to this journal. Our online recommendation form is a simple way to make your librarian aware that this journal is valuable to your research. Recommend now at http://www.nature.com/librec/svc/request/makeCommRequest?id=2.   Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to British Journal of Cancer. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2012 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.